(Q44827042)

English

Treatment of myelodysplastic syndromes with retinoic acid and 1 alpha-hydroxy-vitamin D3 in combination with low-dose ara-C is not superior to ara-C alone. Results from a randomized study. The Scandinavian Myelodysplasia Group (SMG).

scientific article published in November 1990

Statements

Treatment of myelodysplastic syndromes with retinoic acid and 1 alpha-hydroxy-vitamin D3 in combination with low-dose ara-C is not superior to ara-C alone. Results from a randomized study. The Scandinavian Myelodysplasia Group (SMG). (English)
E Hellström
K H Robèrt
J Samuelsson
C Lindemalm
G Grimfors
I Winqvist
R Billström
J Carneskog
1 November 1990
255-261

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit